Abstract | OBJECTIVE: METHODS: Retrospective study of 53 primary penetrating keratoplasties for HSV keratitis at an eye hospital from January 1, 1989, through December 31, 1996. Medical records were analyzed for history of HSV keratitis, preoperative neovascularization, and disease activity. Postoperative use of acyclovir, recurrence of HSV keratitis, rejection, uveitis or edema, and graft failure were evaluated. RESULTS: Twenty-four patients (mean +/- SD follow-up, 44.7 +/- 32.6 months) received no acyclovir and were compared with 20 patients, (mean +/- SD follow-up, 28.8 +/- 16.7 months), who received 400 mg acyclovir twice a day for at least 1 year. No patient in the acyclovir group had a recurrence of dendritic keratitis in the first year compared with 5 (21%) of the patients who did not receive acyclovir (P = .03). No patient had graft failure in the acyclovir group compared with 4 (17%) in the group without acyclovir after 1 year of follow-up (P = .06). CONCLUSION:
|
Authors | F P Tambasco, E J Cohen, L H Nguyen, C J Rapuano, P R Laibson |
Journal | Archives of ophthalmology (Chicago, Ill. : 1960)
(Arch Ophthalmol)
Vol. 117
Issue 4
Pg. 445-9
(Apr 1999)
ISSN: 0003-9950 [Print] United States |
PMID | 10206570
(Publication Type: Clinical Trial, Journal Article)
|
Chemical References |
- Antiviral Agents
- Acyclovir
|
Topics |
- Acyclovir
(therapeutic use)
- Administration, Oral
- Antiviral Agents
(therapeutic use)
- Corneal Edema
(prevention & control)
- Drug Evaluation
- Female
- Follow-Up Studies
- Graft Rejection
(prevention & control)
- Herpesvirus 1, Human
- Humans
- Keratitis, Dendritic
(drug therapy, surgery)
- Keratoplasty, Penetrating
- Male
- Middle Aged
- Postoperative Complications
(prevention & control)
- Recurrence
- Retrospective Studies
- Uveitis, Anterior
(prevention & control)
- Visual Acuity
|